Good update.
I see this as the biggest challenge for AusCann, well MC in general, bridging the gap to GP's and providing them with the resources and guidance to have confidence in determining what chronic pain symptoms patients present with make them suitable candidates for considering cannbanoid based prescribed treatments.
